Newron Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 1/6
Newron Pharmaceuticals has a total shareholder equity of €-29.9M and total debt of €48.0M, which brings its debt-to-equity ratio to -160.6%. Its total assets and total liabilities are €25.9M and €55.8M respectively.
Key information
-160.6%
Debt to equity ratio
€48.03m
Debt
| Interest coverage ratio | n/a |
| Cash | €12.60m |
| Equity | -€29.91m |
| Total liabilities | €55.77m |
| Total assets | €25.87m |
Recent financial health updates
We Think Newron Pharmaceuticals (VTX:NWRN) Has A Fair Chunk Of Debt
Nov 06
Newron Pharmaceuticals (VTX:NWRN) Has Debt But No Earnings; Should You Worry?
Apr 01Recent updates
Here's Why We Think Newron Pharmaceuticals S.p.A.'s (VTX:NWRN) CEO Compensation Looks Fair for the time being
Apr 11We Think Newron Pharmaceuticals (VTX:NWRN) Has A Fair Chunk Of Debt
Nov 06Shareholders May Be Wary Of Increasing Newron Pharmaceuticals S.p.A.'s (VTX:NWRN) CEO Compensation Package
Apr 06Newron Pharmaceuticals (VTX:NWRN) Has Debt But No Earnings; Should You Worry?
Apr 01A Look At Newron Pharmaceuticals' (VTX:NWRN) Share Price Returns
Feb 25Financial Position Analysis
Short Term Liabilities: NWRN has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: NWRN has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: NWRN has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: NWRN's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NWRN has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if NWRN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.